The DOI matches its Crossref record, with a small difference in title or year; 112 of the 113 references it cites were found in a registry or an index.
Diabetes and Pancreatic Cancer: Chicken or Egg?
Abstract
OBJECTIVES: Although half of all patients with pancreatic cancer are diabetic at the time of diagnosis, it remains unclear whether the diabetes associated with pancreatic cancer is a cause or an effect of the malignancy. METHODS: Epidemiologic studies were reviewed, the geographic prevalence of diabetes and the incidence of pancreatic cancer were examined, and clinical and laboratory studies were reviewed. RESULTS: Long-standing diabetes increases the risk of pancreatic cancer by 40% to 100%, and recent-onset diabetes is associated with a 4- to 7-fold increase in risk, such that 1% to 2% of patients with recent-onset diabetes will develop pancreatic cancer within 3 years. Treatment of diabetes or morbid obesity decreases the risk of pancreatic cancer, and metformin therapy decreases the risk due to both its antidiabetic and antineoplastic effects. Recent-onset diabetes associated with pancreatic cancer likely represents secondary or type 3 diabetes. The discrimination of type 3 diabetes from the more prevalent type 2 diabetes may identify the high-risk subgroup of diabetic patients in whom potentially curable pancreatic cancer may be found. CONCLUSIONS: Type 2 and type 1 diabetes mellitus increase the risk of pancreatic cancer with a latency period of more than 5 years. Type 3 diabetes mellitus is an effect, and therefore a harbinger, of pancreatic cancer in at least 30% of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been proven that there is 1–2% of diabetic patients who will develop pancreatic cancer in 3 years (118).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [118]
Citations
Cites
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,710
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Landis, S., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Cited by
Sorted by citations
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484
New insights into pancreatic cancer-induced paraneoplastic diabetes
Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.49 · Cited by 339
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Becker, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11182 · Cited by 357
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Sadeghi, N., Abbruzzese, J. L., Yeung, S. J., Hassan, M. M., & Li, D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2994 · Cited by 308
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 256
Self-citationDiabetes mellitus secondary to pancreatic diseases (type 3c)—are we neglecting an important disease?
Ewald, N., & Bretzel, R. G. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.12.017 · Cited by 235
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Diagnosis and treatment of diabetes mellitus in chronic pancreatitis
Ewald, N. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i42.7276 · Cited by 240
Early Diagnosis of Pancreatic Cancer: Challenges and New Developments
Kaur, S., Baine, M. J., Jain, M., Sasson, A. R., & Batra, S. K. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.69 · Cited by 221
Torres, M. P., Rachagani, S., Purohit, V., Pandey, P., Joshi, S., Moore, E. D., Johansson, S. L., Singh, P. K., Ganti, A. K., & Batra, S. K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.031 · Cited by 202
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
Batabyal, P., Hoorn, S. V., Christophi, C., & Nikfarjam, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3625-6 · Cited by 189
Diabetes and pancreatic cancer
Cui, Y., & Andersen, D. K. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0105 · Cited by 160
Self-citationDiabetes and cancer: Epidemiological and biological links
Wang, M., Yang, Y., & Liao, Z. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i6.227 · Cited by 158
Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.483 · Cited by 139
Karnevi, E., Said, K., Andersson, R., & Rosendahl, A. H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-235 · Cited by 99
Cancer risk in immune-mediated inflammatory diseases (IMID)
Beyaert, R., Beaugerie, L., Assche, G. V., Brochez, L., Renauld, J., Viguier, M. A., Cocquyt, V., Jérusalem, G., Machiels, J., Prenen, H., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-98 · Cited by 127
ABO blood group, hepatitis B viral infection and risk of pancreatic cancer
Wang, D., Chen, D., Ren, C., Wang, Z., Qiu, M., Luo, H., Zhang, D., Wang, F., Li, Y., & Xu, R. (2011) · International Journal of Cancer · doi:10.1002/ijc.26376 · Cited by 126
Epidemiology and risk factors of pancreatic cancer.
Capasso, M., Franceschi, M., Rodriguez-Castro, K. I., Crafa, P., Cambiè, G., Miraglia, C., Barchi, A., Nouvenne, A., Leandro, G., Meschi, T., et al. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i9-s.7923 · Cited by 90
Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges
Wu, B., Sodji, Q. H., & Oyelere, A. K. (2022) · Cancers · doi:10.3390/cancers14030552 · Cited by 92
Colmers-Gray, I. N., Bowker, S. L., Tjosvold, L., & Johnson, J. A. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.08.011 · Cited by 88
Survival Among Patients With Pancreatic Cancer and Long-Standing or Recent-Onset Diabetes Mellitus
Yuan, C., Rubinson, D. A., Qian, Z. R., Wu, C. H., Kraft, P. L., Bao, Y., Ogino, S., Ng, K., Clancy, T. E., Swanson, R. S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.5688 · Cited by 87
Management of pancreatogenic diabetes: challenges and solutions
Makuc, J. (2016) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s99701 · Cited by 84
ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer
Huang, Y.-H., Hu, J., Chen, F., Lecomte, N., Basnet, H., David, C. J., Witkin, M. D., Allen, P. J., Leach, S. D., Hollmann, T. J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0529 · Cited by 78
Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Menini, S., Iacobini, C., Vitale, M., Pesce, C. M., & Pugliese, G. (2021) · Cancers · doi:10.3390/cancers13020313 · Cited by 79
Association between Allergies and Risk of Pancreatic Cancer
Cotterchio, M., Lowcock, E. C., Hudson, T. J., Greenwood, C. M. T., & Gallinger, S. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0965 · Cited by 69
Amin, S., Mhango, G., Lin, J. J., Aronson, A., Wisnivesky, J. P., Boffetta, P., & Lucas, A. L. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.288 · Cited by 70
A review of lifestyle and environment risk factors for pancreatic cancer
Zanini, S., Renzi, S., Limongi, A. R., Bellavite, P., Giovinazzo, F., & Bermano, G. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.040 · Cited by 67
Association between cholesterol intake and pancreatic cancer risk: Evidence from a meta-analysis
Chen, H., Qin, S., Wang, M., Zhang, T., & Zhang, S. (2015) · Scientific Reports · doi:10.1038/srep08243 · Cited by 63
The biological and pharmacological connections between diabetes and various types of cancer
Wang, X., & Ding, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153641 · Cited by 60
Chen, M., Tsan, Y., Liou, J., Lee, Y., Wu, M., Chiu, H., Wang, H., & Chen, P. (2015) · International Journal of Cancer · doi:10.1002/ijc.29813 · Cited by 59
Preziosi, G., Oben, J. A., & Fusai, G. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2014.02.003 · Cited by 55
Vujasinović, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18432 · Cited by 55
Lam, B., Shrivastava, S. K., Shrivastava, A., Shankar, S., & Srivastava, R. K. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15413 · Cited by 53
Brodovicz, K. G., Kou, T. D., Alexander, C. M., O’Neill, E. A., Engel, S. S., Girman, C. J., & Goldstein, B. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01667.x · Cited by 52
Strategies for early detection of resectable pancreatic cancer
Okano, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11230 · Cited by 50
The bidirectional interation between pancreatic cancer and diabetes
Li, J., Cao, G., Ma, Q., Liu, H., Li, W., & Han, L. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-171 · Cited by 49
Diet and Pancreatic Cancer Prevention
Casari, I., & Falasca, M. (2015) · Cancers · doi:10.3390/cancers7040892 · Cited by 50
How grim is pancreatic cancer?
Weledji, E. P., Enow-Orock, G. E., Mokake, M., & Sinju, M. (2016) · Oncology Reviews · doi:10.4081/oncol.2016.294 · Cited by 49
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 53
Are Risk Factors Associated with Outcomes in Pancreatic Cancer?
Wang, D., Wang, Z.-Q., Zhang, L., Qiu, M.-Z., Luo, H., Ren, C., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041984 · Cited by 46
Wang, Y., Zhang, F.-C., & Wang, Y. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4449 · Cited by 46
The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
Li, Y., Bian, X., Wei, S., He, M., & Yang, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s211972 · Cited by 49
Lee, J., Hong, E. M., Kim, J. H., Jung, J. H., Park, S. W., Koh, D. H., Choi, M. H., Jang, H. J., & Kae, S. H. (2019) · Journal of Cancer · doi:10.7150/jca.26380 · Cited by 46
Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review
Biadgo, B., & Abebe, M. (2016) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2016.67.4.168 · Cited by 41
The practical importance of recognizing pancreatogenic or type 3c diabetes
Andersen, D. K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2285 · Cited by 41
Self-citationRisk factors for new-onset diabetes mellitus after distal pancreatectomy
Dai, M., Cheng, X., Shi, N., Wang, S., Wu, G., Liao, Q., Zhang, T., Chen, G., Wu, W., Guo, J., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001778 · Cited by 44
Altered profile of serum microRNAs in pancreatic cancer‐associated new‐onset diabetes mellitus
Dai, X., Pang, W., Zhou, Y., Yao, W., Xia, L., Wang, C., Chen, X., Zen, K., Zhang, C., & Yuan, Y. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12313 · Cited by 38
Cigarette smoking, elevated fasting serum glucose, and risk of pancreatic cancer in Korean men
Yun, J. E., Jo, I., Park, J., Kim, M. T., Ryu, H., Odongua, N., Kim, E., & Jee, S. H. (2006) · International Journal of Cancer · doi:10.1002/ijc.21816 · Cited by 37
Bhaw‐Luximon, A., & Jhurry, D. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2178-4 · Cited by 34
Tan, L., Ye, X., Zhou, Y., Yu, M., Fu, Z., Chen, R., Zhuang, B., Zeng, B., Ye, H., Gao, W., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-92 · Cited by 32
Song, L., Guo, J., Chang, R., Peng, X., Li, J., Xu, X., Zhan, X., & Zhan, L. (2018) · Cancer Science · doi:10.1111/cas.13591 · Cited by 32
Ito, M., Makino, N., Matsuda, A., Ikeda, Y., Kakizaki, Y., Saito, Y., Ueno, Y., & Kawata, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040807 · Cited by 31
Pancreatic cancer: Translational research aspects and clinical implications
Ansari, D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i13.1417 · Cited by 30
Li, X., Xu, H., & Gao, P. (2018) · Medical Science Monitor · doi:10.12659/msm.913769 · Cited by 33
Glycemic Change After Pancreaticoduodenectomy
Wu, J., Ho, T., Kuo, T., Yang, C., Lai, H., Chiang, P., Hsieh, S., Lai, F., & Tien, Y. (2015) · Medicine · doi:10.1097/md.0000000000001109 · Cited by 28
Clift, A. K., Tan, P. S., Patone, M., Liao, W., Coupland, C. A. C., Bashford-Rogers, R. J. M., Sivakumar, S., & Hippisley‐Cox, J. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02693-9 · Cited by 29
Is diabetes mellitus a risk factor for pancreatic cancer?
Pezzilli, R. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i30.4861 · Cited by 24
Lee, S., Hwang, H. K., Kang, C. M., & Lee, W. J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001099 · Cited by 25
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
Koltai, T. (2023) · Cancers · doi:10.3390/cancers15184430 · Cited by 22
Diabetes and pancreatic cancer
Chaudhry, Z. W., Hall, E., Kalyani, R. R., Cosgrove, D., & Yeh, H. (2013) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2013.10.006 · Cited by 23
Type 2 Diabetes Mellitus and Pancreatic Cancer
McAuliffe, J. C., & Christein, J. D. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.02.003 · Cited by 22
Sánchez, M. L., Rodriguez, F. D., & Coveñas, R. (2023) · Cancers · doi:10.3390/cancers15061694 · Cited by 23
Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis
Wang, J., Shen, H., Zhan, M., Wang, W., & Dong, Y. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s95744 · Cited by 21
Role of Fibre in Nutritional Management of Pancreatic Diseases
Ribichini, E., Stigliano, S., Rossi, S., Zaccari, P., Sacchi, M. C., Bruno, G., Badiali, D., & Severi, C. (2019) · Nutrients · doi:10.3390/nu11092219 · Cited by 21
Insulin Therapy and Cancer in Type 2 Diabetes
Mannucci, E. (2012) · ISRN Endocrinology · doi:10.5402/2012/240634 · Cited by 21
The dual role of HMGB1 in pancreatic cancer
Kang, R., & Tang, D. (2018) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000002 · Cited by 19
Moz, S., Basso, D., Padoan, A., Bozzato, D., Fogar, P., Zambon, C., Pelloso, M., Sperti, C., de Kreutzenberg, S. V., Pasquali, C., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.018 · Cited by 19
Tiffon, C. (2020) · Biomedicines · doi:10.3390/biomedicines8060178 · Cited by 21
Glargine safety, diabetes and cancer
Rendell, M., Aktürk, H. K., & Tella, S. H. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.770469 · Cited by 18
He, X., Han, W., Hu, S., Zhang, M., Hua, J., & Peng, S. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2220-x · Cited by 18
Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics
Yan, Y., Gao, R., Trinh, T. L. P., & Grant, M. B. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0250 · Cited by 17
Early detection of sporadic pancreatic cancer: time for change
Fric, P., Šedo, A., Škrha, J., Bušek, P., Laclav, M., Škrha, P., & Zavoral, M. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000904 · Cited by 16
Padoan, A., Seraglia, R., Basso, D., Fogar, P., Sperti, C., Moz, S., Greco, E., Marchet, A., Manzoni, G. D., Zambon, C., et al. (2012) · Pancreas · doi:10.1097/mpa.0b013e318273096c · Cited by 16
Pergolini, I., Jäger, C., Safak, O., Göß, R., Novotny, A., Ceyhan, G. O., Frieß, H., & Demir, İ. E. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.090 · Cited by 16
Spatial modelling of type II diabetes outcomes: a systematic review of approaches used
Baker, J., White, N. M., & Mengersen, K. L. (2015) · Royal Society Open Science · doi:10.1098/rsos.140460 · Cited by 18
Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines
Zechner, D., Albert, A.-C., Bürtin, F., & Vollmar, B. (2017) · Journal of Cancer · doi:10.7150/jca.17972 · Cited by 16
Moz, S., Basso, D., Bozzato, D., Galozzi, P., Navaglia, F., Negm, O. H., Arrigoni, G., Zambon, C., Padoan, A., Tighe, P. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12068 · Cited by 15
Rahimi, E. F., Batra, S., Thosani, N. C., Singh, H., & Guha, S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4170-x · Cited by 15
Li, P., Hu, Y., Scélo, G., Myrskylä, M., & Martikainen, P. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102307 · Cited by 14
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer
Słotwiński, R., & Słotwińska, S. M. (2017) · Central European Journal of Immunology · doi:10.5114/ceji.2016.65139 · Cited by 14
Cohrs, C. M., Chen, C., Atkinson, M. A., Drotar, D. M., & Speier, S. (2023) · Diabetes · doi:10.2337/dbi20-0018 · Cited by 13
Intelligent system for diabetes prediction in patients with chronic pancreatitis
Shesternikova, O. P., Агафонов, М. А., Vinokurova, L. V., Pankratova, E. S., & Финн, В. К. (2016) · Scientific and Technical Information Processing · doi:10.3103/s0147688216050051 · Cited by 13
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Novosyadlyy, R., Yakar, S., & LeRoith, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_36 · Cited by 12
Diabetes and Cancer: Epidemiological, Clinical, and Experimental Perspectives
Tseng, C., Chen, C., & Landolph, J. R. (2012) · Experimental Diabetes Research · doi:10.1155/2012/101802 · Cited by 13
Diabetes Mellitus in Pancreatic Cancer Patients in the Czech Republic: Sex Differences
Trna, J., Dítě, P., Adamcová, A., Crawford, B. J., & Hermanová, M. (2012) · Experimental Diabetes Research · doi:10.1155/2012/414893 · Cited by 11
Kwon, M., Leem, S., Yoon, J. H., & Park, T. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0543-4 · Cited by 10
Śliwińska‐Mossoń, M., Milnerowicz, S., & Milnerowicz, H. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118764062 · Cited by 13
Terasaki, F., Sugiura, T., Okamura, Y., Ito, T., Yamamoto, Y., Ashida, R., Ohgi, K., & Uesaka, K. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-01874-3 · Cited by 9
Pancreatic Cancer: Updates on Translational Research and Future Applications
Sarris, E., Syrigos, K. N., & Saif, M. W. (2013) · PubMed · doi:10.6092/1590-8577/1466 · Cited by 9
Incidence of pancreatic cancer in Greenland 2000–2010
Kirkegaard, J. (2012) · International Journal of Circumpolar Health · doi:10.3402/ijch.v71i0.18368 · Cited by 9
The early diagnosis of pancreatic cancer and diabetes: what's the relationship?
Zhang, C., Yang, G.-S., Ling, Y., Chen, G., & Zhou, T. (2014) · PubMed Central · doi:10.3978/j.issn.2078-6891.2014.055 · Cited by 8
RetractedBitterman, D. S., Winter, K. A., Hong, T. S., Fuchs, C. S., Regine, W. F., Abrams, R. A., Safran, H. P., Hoffman, J. P., Benson, A. B., Kasunic, T., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.042 · Cited by 8
Pancreatogenic diabetes / type 3c diabetes: status update on the problem
Руяткина, Л. А., & Руяткин, Д. С. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-4-28-35 · Cited by 8
Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1
Yu, Q., Zhang, Z., & Zhang, H. (2021) · Cancer Management and Research · doi:10.2147/cmar.s293473 · Cited by 7
Early pancreatic carcinogenesis – risk factors, early symptoms, and the impact of antidiabetic drugs
Fric, P., Škrha, J., Šedo, A., Bušek, P., Kmochová, K., Laclav, M., Solař, S., Bunganič, B., & Zavoral, M. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000646 · Cited by 7
Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
Goldberg, R., Meirovitz, A., Abecassis, A., Hermano, E., Rubinstein, A. M., Nahmias, D., Grinshpun, A., Peretz, T., & Elkin, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01405 · Cited by 7
Feingold, K. R. (2015) · Europe PMC (PubMed Central) · Cited by 7
Pancreatic Cancer Prevention and the 2010 Dietary Guidelines for Americans
Harris, D. M., Srihari, P., & Go, V. L. W. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182203e3c · Cited by 6
Diabetes and cancer: glucose control impact on survival and tumor outcomes
Ruggeri, R. M., Grossrubatscher, E. M., Arrivi, G., Ciocca, E., Filice, A., Golisano, B., Mazzilli, R., Prinzi, N., Colao, A., Faggiano, A., et al. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10040-x · Cited by 7
Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior
Bianconi, D., Fabian, E., Herac, M., Kieler, M., Thaler, J., Prager, G. W., & Unseld, M. (2022) · Journal of Cancer · doi:10.7150/jca.70500 · Cited by 5
Metadata
- Authors
- Magruder, J. T., Elahi, D., & Andersen, D. K.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Magruder, J. Trent
- Elahi, Dariush
- Andersen, Dana K.
- Venue
- Pancreas
- Published
- 2011-04
- Volume
- 40
- Issue
- 3
- Pages
- 339-351
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W2314910395
- Cited by
- 140
- References
- 113
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 13 · 2017: 10 · 2016: 12 · 2015: 11 · 2014: 12 · 2013: 14 · 2012: 20
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pancreas (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial Sloan-Kettering Cancer Center
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- pancreatic cancer, diabetes mellitus, type 3 diabetes, type 2 diabetes, type 1 diabetes, cancer risk, recent-onset diabetes, metformin, obesity, morbid obesity, diabetes treatment, pancreatic cancer incidence
- MeSH terms
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Female, Glucose, Humans, Male, Metformin, Pancreatic Neoplasms, Risk Factors, Biomarkers, Tumor, United States, Causality, Case-Control Studies, Diabetes Complications, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
